Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICARIA trial of azithromycin-based infant care improvement in Sierra Leone
PACTR202004540256535Phase 3Not yet recruiting
- Sponsor
- Barcelona Institute for Global Health
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azithromycin and sulfadoxine + pyrimethamine in malaria and Airways Infection (2 arms), sponsored by Barcelona Institute for Global Health. Primary endpoint: All-cause mortality. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
azithromycinsulfadoxine + pyrimethamine
03
Conditions
malariaAirways Infection
Beyond the preview
Go deeper on PACTR202004540256535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202004540256535.